MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH)

CUSIP: 57060U217

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / PHARMACEUTICAL
Total 13F shares
1,260,319
Share change
+437,318
Total reported value
$78,200,904
Price per share
$62.04
Number of holders
51
Value change
+$27,299,176
Number of buys
25
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 57060U217?
CUSIP 57060U217 identifies PPH - MARKET VECTORS ETF TR - PHARMACEUTICAL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) as of Q2 2014

As of 30 Jun 2014, MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,260,319 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, NIEMANN CAPITAL MANAGEMENT INC, RAYMOND JAMES & ASSOCIATES, MORGAN STANLEY, HighTower Advisors, LLC, BANK OF AMERICA CORP /DE/, MACROVIEW INVESTMENT MANAGEMENT LLC, COLUMBIA CAPITAL LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and MONTAG A & ASSOCIATES INC. This page lists 51 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.